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Abstract.  The dystrophin-glycoprotein complex was 
tested for interaction with several components of the 
extracellular matrix as well as actin. The 156-kD 
dystrophin-associated glycoprotein (156-kD  dystrogly- 
can) specifically bound laminin in a calcium- 
dependent manner and was inhibited by NaC1 (IC5o = 
250 mM) but was not affected by 1,000-fold  (wt/wt) 
excesses of lactose, IKVAV, or YIGSR peptides. Lami- 
nin binding was inhibited by heparin (IC5o =  100 
/~g/ml), suggesting that one of the heparin-binding do- 
mains of laminin is involved in binding dystroglycan 
while negatively charged oligosaccharide moieties on 
dystroglycan were found to be necessary for its 
laminin-binding activity. No interaction between any 
component of the dystrophin-glycoprotein complex and 
fibronectin, collagen I, collagen IV, entactin, or hepa- 
ran sulfate proteoglycan was detected by 125I-protein 
overlay and/or extracellular matrix protein-Sepharose 
precipitation. In addition, laminin-Sepharose quantita- 
tively precipitated purified dystrophin-glycoprotein 
complex, demonstrating that the laminin-binding site 
is accessible when dystroglycan is associated with the 
complex. Dystroglycan of nonmuscle tissues also 
bound laminin. However, the other proteins of the stri- 
ated muscle dystrophin-glycoprotein complex appear 
to be absent, antigenically dissimilar or less tightly as- 
sociated with dystroglycan in nonmuscle tissues. Fi- 
nally, we show that the dystrophin-glycoprotein com- 
plex cosediments with F-actin but does not bind 
calcium or calmodulin. Our results support a role for 
the striated muscle dystrophin-glycoprotein complex in 
linking the actin-based cytoskeleton with the extracel- 
lular matrix. Furthermore, our results suggest that 
dystrophin and dystroglycan may play substantially 
different functional roles in nonmuscle tissues. 
S 
KELETAL muscle dystrophin  (Anderson and Kunkel, 
1992) has been isolated as part of a large, tightly as- 
sociated oligomeric complex containing six other sar- 
colemmal proteins, four of which are glycoproteins (Ervasti 
et al.,  1990; Yoshida and Ozawa, 1990; Oldendieck et al., 
1991b).  Biochemical  characterization of the  dystrophin- 
glycoprotein complex suggests that four of the dystrophin- 
associated proteins are integral membrane proteins (Ervasti 
and  Campbell,  1991) which bind  the  cysteine-rich  and 
COOH-terminal  domains  of dystrophin  (Suzuki  et  al., 
1992), thus linking dystrophin to a highly glycosylated, ex- 
tracellular component of 156 kD (Ervasti  and Campbell, 
1991).  In  support  of its  proposed  extracellular location 
(Ervasti and Campbell,  1991), the 156-kD dystrophin-asso- 
ciated gycoprotein (156 kD dystroglycan) was shown to bind 
laminin 0braghimovoBeskrovnaya  et al.,  1992). Further- 
more, dystrophin has been shown to colocalize with laminin 
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in  cultured myotubes  (Dickson  et  al.,  1992) while  the 
dystrophin-glycoprotein  complex  and  laminin  have  been 
shown to codistribute  in cardiac muscle (Klietsch  et all., 
1993). Recently, Hemmings et al. (1992) demonstrated that 
a chimera comprising the first 233 amino acids of dystrophin 
and the last 645  amino acids of smooth muscle o~-actinin 
localized to actin-containing  structures when expressed in 
COS cells. In addition, bacterially expressed fusion proteins 
corresponding to the putative actin-binding domain of dys- 
trophin have been shown to cosediment with F-actin (Hem- 
mings et al., 1992; Way et al., 1992). Nuclear magnetic res- 
onance experiments with synthetic peptides  corresponding 
to defined regions  of the NH2-terminal domain of dystro- 
phin provide evidence for two actin-binding sites on dystro- 
phin located at amino acids 1%26 and 128-156 (Levine et 
al.,  1992). Taken together,  these results  suggest that the 
marked reduction of  the dystrophin-associated glycoproteins 
in muscle from nu/x mice and DMD patients (Ervasti et al., 
1990; Ohlendieck and Campbell,  1991b; Ohlendieck et al., 
1993) disrupts  a critical linkage between the actin-based, 
sarcolemmal cytoskeleton, and the extracellular matrix (Er- 
vasti and Campbell,  1993) thus rendering dystrophic muscle 
fibers more susceptible to necrosis. 
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lation of collagen in Duchenne muscular dystrophy (Duance 
et al.,  1980; Rampoldi et al.,  1986; Marshall et al.,  1989). 
These results suggest that the interaction of other extracellu- 
lar matrix molecules with the sarcolemmal membrane may 
be affected by the absence of dystrophin. Furthermore, these 
results  raise the question of whether the dystrophin-glyco- 
protein complex can interact with extracellular matrix mole- 
cules other than laminin. 
With regard to F-actin binding to dystrophin,  the experi- 
ments  were  performed  with  dystrophin  polypeptide  frag- 
ments (Hemmings et al.,  1992; Way et al.,  1992; Levine et 
al,, 1992) which may expose binding sites not present in na- 
tive dystrophin.  For example,  the targeting  of the dystro- 
phin/a-actinin  chimera  to  the  actin  fibers  and  adhesion 
plaques of COS cells (Hemmings et al.,  1992) is contrasted 
by the diffuse cytoplasmic (Ascadi et al.,  1991) or plasma 
membrane location (Lee et al.,  1991) of full-length  dystro- 
phin constructs  expressed in COS cells.  Furthermore,  pro- 
teolytic cleavage of synapsin I results in fragments exhibiting 
threefold greater affinity for actin than native synapsin (Bah- 
ler et al.,  1989).  Since the NHe-terminal  fusion protein of 
dystrophin  binds F-actin  with an estimated  Kd of 44  #M 
(Way et al., 1992), a threefold  lower actin-binding  affinity 
for native dystrophin corresponding to the difference  be- 
tween synapsin I  fragments and native  synapsin would bring 
into  question the physiological  relevance  of  F-actin  binding 
to dystrophin. 
To address these issues, we tested the purified dystrophin- 
glycoprotein complex for interaction  with several  purified 
components of the extraceUular matrix as well as actin. Our 
results  demonstrate  that  dystroglycan  specifically  binds 
laminin in a calcium- and ionic strength-dependent manner, 
whether alone or as part of the dystrophin-glycoprotein  com- 
plex. Nonmuscle dystroglycan also binds laminin.  However, 
the other proteins in the dystrophin-glycoprotein  complex in 
striated muscle tissues appear to be absent, antigenically dis- 
similar, or less tightly associated in nonmuscle tissues. Fi- 
nally,  we  show that the dystrophin-glycoprotein  complex 
cosediments with F-actin but, unlike spectrin or a-actinin, 
does not bind calcium or calmodulin. Our results support a 
role for the striated muscle dystrophin-glycoprotein  complex 
in  linking  the  actin  cytoskeleton  with  the  extracellular 
matrix. 
Materials and Methods 
Isolation of  Rabbit Tissue Membranes 
KCl-washed rabbit skeletal muscle, cardiac muscle, brain and lung mem- 
branes, skeletal muscle triads, and surface membranes were prepared as 
previously described (Sharp et al.,  1987; Ohlendieck et ai.,  1991b). 
Preparation of  Alkaline Extracts  from 
Surface Membranes 
5 mg of skeletal muscle surface membranes were diluted to a volume of 2 
mi with 50 mM Tris-HC1, pH 7.4, 0.1 mM PMSF, 0.75 mM benzamidine, 
2.5/tg/mi aprotinin, 93/~g/mi iodeacetamide, 2.5/tg ml leupeptin and 0.5 
/~g/ml pepstatin A, and titrated to pH 12 with 10 M NaOH. After a 1-h incu- 
bation at 22°C with mixing, the samples were centrifuged for 30 rain at 
100,000 g. The resulting supernatant (alkaline surface membrane extract) 
was  decanted from the membrane pellets and titrated to  pH  7.4  with 
1 M  HC1. 
Purification of Dystrophin-Glycoprotein Complex 
The dystrophin-glycoprotein  complex was prepared from rabbit skeletal 
muscle membranes as previously described (Ervasti and Campbell, 1991). 
Alkaline-dissociated  dystrophin-glycoprotein  complex was prepared as pre- 
viously described (Ervasti et ai.,  1991). 
Nitrocellulose Transfer Overlays 
EHS laminin (Sigma Chemical Co., St. Louis, MO; Collaborative Research 
Inc., Lexington, MA, Upstate Biotechnology, or the kind gift of Dr. Hynda 
K.  Kleinman),  bovine plasma  fibronectin (Sigma Chem.  Co.),  human 
placenta merosin (Telios),  recombinant mouse entactin (Upstate Biotech- 
nology),  heparan sulfate  pmteoglycan (Collaborative Research), and bovine 
brain calmodulin (Calbiochem-Novabiochem  Corp., La Jolla, CA) were io- 
dinated with [l~I]Nal by the Diabetes, Endocrinology Research Center at 
the University of Iowa using a lactoperoxidase/glucose  oxidase reaction. 
The iodinated extracellular matrix protein overlay procedure used was 
previously described (lbraghimov-Beskrovnaya  et al., 1992). In the case of 
laminin, for example,  nitrocellulose transfers of SDS polyacrylamide  gels 
containing the various samples were blocked overnight at room temperature 
in 140 mM NaC1, 1 mM CaC12, 1 mM MgC12, 10 mM triethanolamine, 
pH 7.6 (Ix LBB) containing 5% nonfat dry milk, rinsed briefly in lx LBB, 
and incubated for 2-3 h at room temperature in Ix LBB containing 3 % BSA 
and 0.090/~g/ml (0.1 nM) 125I-laminin. The nitrocellulose transfers  were 
washed twice for 30 rain at room temperature with 25-50 ml of lx LBB, 
dried, and exposed to X-ray film. Lactose, IKVAV and YIGSR peptides, 
bovine trachea chondroitin sulfate A, bovine cornea keratan sulfate,  and 
porcine intestinal mucosa heparin were all purchased from Sigma Chem. 
Co. and tested for their effects on laminin binding to dystroglycan by inclu- 
sion in the overlay medium at the indicated concentration  or wt/wt ratio with 
respect to the 125I-laminin concentration. The effects of Jacalin, Maackia 
amurensis leetin H, peanut agglutinin, Con A, and wheat germ agglutinin 
(all purchased from Vector Labs Inc., Buriingeme,  CA) on laminin binding 
to dystroglycan were tested at 1,000-fold (wt/wt) excess of the 125I-laminin 
concentration. 
Overlay of nitrocellulose transfers with 45CAC12 (Dupont New England 
Nuclear,  Boston, MA) was performed by the method previously  described 
to demonstrate calcium binding to erythrocyte and brain speetrin (Wallis 
et al.,  1992). 
Overlay of nitrocellulose transfers with 125I-calmodulin in the presence 
of 1 mM CaCI2 or l  mM EGTA was performed as previously described 
(Flanagan and Yost, 1984).  Transfers  overlaid with 125I-calmodulin also 
contained 0.3/~g rat brain Calmodulin kinase II (Hashimoto et al.,  1987) 
which was the kind gift of Drs.  Roger Colbran and Thomas Soderling. 
AJ~inity Precipitation and Chromatography 
EHS tumor laminin (Upstate Biotechnology  or the kind gift of Dr. Hynda 
K. Kleinman), bovine plasma fibronectin (Sigma Chem. Co.), gelatin from 
porcine skin (Sigma Chem. Co.),  rat tail collagen I  (Collaborative Re- 
search), and EHS tumor collagen IV (Collaborative Research) were coupled 
to CNBr-activated  Sepharose 413 (Sigma Chem. Co.). 0.9 ml of alkaline sur- 
face membrane extracts  were diluted twofold with 0.28 M  NaCI, 2 mM 
CaC12, 2 mM MgC12, 20 mM triethanolamine, pH 7.6 (2x LBB) and 0.3 
ml applied to 0.1 ml of iaminin-, fibronectin-, gelatin-, collagen I-, or colla- 
gen IV-Sepharose which had been preequllibrated with Ix LBB containing 
3 % BSA and washed with three 0.3-ml aliquots of Ix LBB. After incubating 
overnight at 4°C with mixing, the Sepharose matrices were separated from 
the supernatants by a brief centrifugation and the supernatants (voids) re- 
moved. The Sepharose matrices were washed with three 0.3-ml aliquots of 
Ix LBB, and then sohibilized in 0.3 ml of Ix LBB plus sample buffer for 
gel  analysis.  Equal  volumes  of  alkaline  surface  membrane  extracts, 
Sepharose voids, washes,  and Sepharose matrices were analyzed by SDS- 
PAGE and immunoblotting. The collagen matrices were determined to be 
functional by their ability to precipitate purified fibroneetin (all three ma- 
trices) as well as laminin (collagen IV-Sepharose) using the same method 
under the conditions described above. Dystroglycan binding to heparin was 
tested under identical conditions except  heparin-agarose (Sigma  Chem, 
Co.) was used as the affinity matrix and 8% beaded agerose (Sigma Chem. 
Co.) was included as a control. 
To test for dystrophin-glycoprotein  complex binding to the various Seph- 
arose matrices, untreated or alkaline-dissociated  dystrophin-glycoprotein 
complex (44/~g) was diluted fourfold such that the final buffer conditions 
were 0.1% digitonin, 44 mM NaCI,  1 mM CaCI2,  1 m_M MgCl2,  I0/~g/ 
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Co.), 50 mM Tris-HCl, pH 7.4 (DLB)  I. 0.3 ml of the diluted dystrophin- 
glycoprotein complex was added to 0.1 ml of laminin-, flbronectin-, gelatin-, 
collagen I-, or collagen  IV-Sepharose  which had been first washed with 0.5 
ml DLB containing 10 mM Tris-EDTA,  pH 8.0, followed by three 0.5-ml 
washes  with DLB.  After incubation for  12 h  with mixing at 4°C,  the 
Sepharose matrices were washed three times with 0.3-ml aliquots of DLB 
and subsequently eluted with twu 0.3-mi aliquots (1 h each elution) Of DLB 
containing 10 mM Tris-EDTA, pH 8.0 (in the case of laminin-Sepharose), 
or with one 0.5-ml aliquot of DLB containing 10 mM Tris-EDTA, pH 8.0, 
and 0.5 M NaCI (all other Sepharose matrices). The Sepbarose matrices 
were then solubilized in 0.3 ml of lx LBB plus sample buffer for gel analy- 
sis. Equal volumes of dystrophin-glycoprotein  complex, Sephasose voids, 
washes, and Sepharose matrices were analyzed by SDS-PAGE and immuno- 
blotting. 
Laminin affinity  chromatography of detergent-solubflized  membranes 
was performed under conditions identical to those used for affinity precipi- 
tation of the dystrophin-glycoprotein  complex.  Twenty-five mg of rabbit 
KCl-washed  skeletal muscle, brain, cardiac muscle, and lung membranes 
were solubflized  in 5 ml of 1% digitonin, 0.44 M NaCI,  0.1 mM PMSF, 
0.75 mM benzamidine, 2.5 t,g/rrd aprotinin, 2.5 t~g ml leupeptin, and 0.5 
/~g/ml pepstatin A and 50 mM Tris-HC1, pH 7.4.3.0 ml of the solubilized 
membranes were diluted tenfold with 1.33 mM CaCl2,  1.33 mM MgCI2, 
13.3  /tg/ml  trans-epoxysuccinyl-E-leucylamido(4-guanidino)-hutane,  50 
rnM Tris-HCl, pH 7.4, to reduce the digitonin and NaCl concentrations to 
0.1% and 44 mM, respectively.  After incubation overnight with mixing at 
4°C with 0.75 mi of laminin-Sepbarose  which had been preequllibrated with 
DLB, the laminin-Sepharose was separated from the supernatant (void) by 
a brief centrifugation, and then washed with five 0.75-mi aliquots of DLB. 
The laminin-Sepharose was subsequently eluted with two 0.75-ml aliquots 
(1 h each solution) of DLB containing 10 mM Tris-EDTA, pH 8.0. The two 
EDTA eluates were pooled and 15 ml of each laminin-Sepharose void was 
concentrated tenfold in a Centriprep 30 for gel analysis.  Equal volumes of 
solubilized membranes, Sepharose voids, and EDTA eluates were analyzed 
by SDS-PAGE and immunoblotting. 
Chemical and Enzymatic Treatments 
Chemical deglycosylation  of alkaline surface membrane extracts using 
trifluoromethanesulfonic acid (TFMS)  was performed as previously de- 
scribed (Burgess and Norman, 1988). Briefly, 1 ml of alkaline surface mem- 
brane extracts were lyophilized in a 5-ml Reactivial (Pierce,  Rockford, IL) 
and incubated under nitrogen for 4 h on ice with 0.392 ml anisole and 0.588 
ml TFMS (Sigma Chem. Co.). The reaction was terminated with 1.568 ml 
ice-cold pyridine/H20 (3:5 vol/vol) and dialyzed at 4°C overnight alter 4 
liters of H20.  The dialyzed  sample was extracted with anhydrous  ether, 
lyophilized,  and resolubilized in  1 ml of H20.  Dystrophin-glycoprotein 
complex was treated with neuraminidase as previously described (Ervasti 
and Campbell, 1991). The dystrophin-glycoprotein  complex was digested 
with alkalase (Novo, New York, NY) by incubating 72 pg of dystrophin- 
glycoprotein complex which had been titrated to pH 9 using 1 M NaOH, 
for 2 h at 60°C in the presence of 0.1% alkalase (Linhardt et al.,  1992). 
Actin Cosedimentation Assay 
The buffer conditions in the actin cosedimentation assay  were based on 
those recently used to demonstrate actin cosedimentation with a fusion pro- 
tein corresponding to the IqH2-terminal domain of dystrophin (Hemmings 
et al., 1992). 0.5 mi of dystrophin-glycoprotein  complex (0.116 mg/ml) was 
applied to a Pharmacia PD-10 column (Sephadex G-25 M), which had been 
preequilibrated with 25 ml of 0.1% digitonin, 0.2 mM CaCI2, 0.2 mM 
ATP, 0.2 mM DTT, I0 mM Tris-HCl, pH 7.4 (ABB), and eluted according 
to the manufacturer's instructions. The PD-10 elnate was concentrated to 
0.25 ml in a Centricon 100 (Amicon, Beverly, MA) for use in the actin 
cosedimentation assay.  Various  amounts of rabbit muscle actin (Sigma 
Chem. Co.) dissolved in ABB were added to 40 ml of the concentrated PD- 
10 elnate and actin polymerization was initiated  by the addition of NaCi and 
MgCl2 to the final concentrations of 100 mM and 3 raM, respectively,  in 
1. Abbreviations used in thispaper: ABB, actin binding buffer (0.1% digi- 
tonin, 0.2 mM CaCI2, 0.2 mM ATE 0.2 mM DTT, 10 mM Tris-HC1, pH 
7.4); DLB, digitonin laminin binding buffer (0.1% digitonin, 44 mM NaC1, 
1 mM CaC12, 1 mM MgCI2, 10/~g/ml trans-epoxysuceinyl-L-leucylamido- 
(4-guanidino)-butane, 50 mM Tris-HC1,  pH 7.4);  LBB, laminin binding 
buffer (140 mM NaC1,  1 mM CaCI2,  1 mM MgCI2,  10 mM triethanol- 
amine, pH 7.6); TFMS, trifluoromethanesulfonic  acid. 
a total volume of 0.1 ml. After incubation at room temperature for 1 h, the 
samples were centrifuged at 100,000 g  for 30 rain, the supernatants re- 
moved, and the acfin pellets re,  suspended in ABB plus SDS sample buffer. 
Equal volumes of the supernatants and resuspended actin pellets were ana- 
lyzed by SDS-PAGE and immunoblotting. 
Antibodies 
Preparation of sheep polyclonal antisera against the dystrophin-glycoprotein 
complex was  previously described (Ohlendieck and Campbell,  1991b). 
Polyclonal  antibodies specific for fusion protein D, which corresponds to 
the core protein of dystroglycan,  were afffinity-purified  from the sheep poly- 
clonal antisera a~ainst the dystrophin-glycoprotein  complex as previously 
described  (Ibraghimov-Beskrovnaya  et al.,  1992).  The preparation and 
characterization of monoclonal antibodies IIH6 and VIA41,  specific  for 
dystroglycan and the dystrophin-specific  monoclonai antibody XIXC2 have 
previously  been described (Ervasti and Campbell,  1991; Ervasti et al., 
1990; Jorgensen et al., 1990; Ohiendieck et al.,  1991/7). Monoclonal anti- 
body HH6 was purified from tissue culture media by a previously described 
method (Imagawa et al., 1987) except Sephacryl S-400 was used instead of 
Sepharose CL-4B.  Monoclonal antibodies specific for chondroitin sulfate 
and keratin sulfate were obtained from Sigma Chem. Co. and ICN Biomedi- 
cals, Inc., Costa Mesa, CA,  respectively. 
SDS-PAGE and Immunoblotting 
SDS-PAGE (Laemmli, 1970) was carried out on 3-12 % gradient gels in the 
presence of  1%  2-mercaptoethanol and  stained  with Coomassie  blue, 
Stains-All  (Campbell et al.,  1983), Alcian Blue (AI-Hakim and Linhardt, 
1991), or transferred to nitrocellulose (Towbin et al.,  1979).  Molecular 
weight standards shown in the figures were purchased from GIBCO BRL 
(Gaithersburg, MD). Nitrocellulose transfers were stained with polyclonal 
antisera, affinity-purified polyclonal  antibodies, or monoclonal antibodies 
as previously  described (Campbell et al.,  1987). Coomassie blue-stained 
gels and autoradiograms were analyzed densitometrically using a model 
300S scanning densitometer (Molecular Dynamics, Inc., Sunnyvale, CA). 
Results 
Laminin-binding Properties of  Dystroglycan 
A number of commercially  available purified extracellular 
matrix components were radiolabeled and tested for binding 
to dystrophin-glycoprotein complex which had been electro- 
phoretically separated on SDS polyacrylamide gels and trans- 
ferred to nitrocellulose. As previously reported (Ibraghimov- 
Beskrovnaya et al.,  1992), 125I-laminin bound to a protein 
band  in  crude  skeletal  muscle  surface  membranes  and 
purified dystrophin-glycoprotein complex corresponding to 
156 kD dystroglycan (Fig.  1 A).  t25I-Merosin also labeled 
dystroglycan,  albeit  more weakly  than  EHS  laminin  (not 
shown).  Overexposed  autoradiograms  revealed additional 
laminin-binding proteins of 100 and 60 kD in the crude sur- 
face membrane preparation (not shown). However, these ad- 
ditional laminin-binding proteins were less abundant in pure 
sarcolemma than in crude muscle membranes,  suggesting 
that they are either peripheral proteins which were removed 
by the KCI wash step or were a component of  a distinct vesi- 
cle population. 
The binding of ~I-laminin to dystroglycan was inhibited 
by the inclusion of 10 mM EDTA (Fig.  1 A). The absence 
of CaCI2, but not MgCl2 from the overlay medium also in- 
hibited  mI-laminin  to  dystroglycan  (not  shown).  ~2sI- 
laminin  binding  to dystroglycan  was  also  completely  in- 
hibited by inclusion of NaC1 to the overlay medium (Fig. 1 
A) with an average half-maximal concentration for inhibition 
(ICs0) of 250 raM. 
The binding of '2q-laminin to dystroglycan was inhibited 
by  the  inclusion  of an  excess  of unlabeled  laminin  but 
Ervasti and Campbell Dystrophin-Glycoprotein Complex Binds Laminin  811 Figure 1. Laminin-binding properties of dystroglycan. Shown in A 
is 50 #g of rabbit skeletal muscle surface membranes (SM) and 10 
#g of dystrophin-glycoprotein complex (DGC) which were elec- 
trophoretically separated on a 3-12% SDS polyacrylamide gel and 
stained with Coomassie blue (CB). Also shown in A is a nitrocellu- 
lose transfer stained with monoclonal antibody IIH6 to dystrogly- 
can (156-DAG) or corresponding autoradiograms of transfers over- 
laid with nSI-laminin in the absence (1251-LAM) or presence of 10 
mM EDTA (EDTA)  or 0.5 M NaCI (NaCI). Shown in B are the cor- 
responding autoradiograms of nitrocellulose transfers containing 4 
#g of electrophoretically separated dystrophin-glycoprotein com- 
plex which were overlaid with  t25I-laminin in the absence  (1251- 
LAM) or presence of 1,000-fold  excesses (wt/wt) of nonradioactive 
laminin (+/_AM), fibronectin (+FIB), IKVAV peptide (+IKVAV), 
YIGSR peptide (+YIGSR), or in the presence of 0.1  M lactose 
(+Lactose). The molecular weight standards (xl0  -3) are indicated 
on the left. 
not fibronectin (Fig.  1 B) or entactin (not shown). Further- 
more, no component of  the dystrophin-glycoprotein  complex 
bound 12q-fibronectin,  ~25I-entactin, or  ~2q-heparan  sulfate 
proteoglycan as assayed by the nitrocellulose transfer overlay 
method (not shown). 
A number of short synthetic peptides corresponding to se- 
quences within laminin can serve as adhesion substrates for 
a variety of cell types and receptors (Yamada,  1991).  Two 
well characterized peptides, YIGSR (Graf et al.,  1987) and 
IKVAV (Tashiro et al.,  1989), had no effect on ~2q-laminin 
binding to dystroglycan when included in 1,000-fold (wt/wt) 
excess to the overlay medium (Fig. 1 B). Lactose, which in- 
hibits laminin binding to a family of galactoside-binding lec- 
tins  (Mecham,  1991),  also  had  no  effect on  ~I-laminin 
binding to dystroglycan (Fig.  1 B). 
Heparin Blocks Laminin Binding to Dystroglycan 
The  ionic  strength  sensitivity of laminin  binding  to dys- 
troglycan  and  its  extensive posttranslational  modification 
(Ervasti  and  Campbell,  1991;  Ibraghimov-Beskrovnaya et 
al., 1992) imply that dystroglycan may bind to one of the do- 
mains  of  laminin  important  in  binding  heparin  CKouzi- 
Koliakos et al.,  1989;  Skubitz et al.,  1988).  Heparin in- 
hibited 125I-laminin binding to dystroglycan with an ICso of 
100 #g/ml while chondroitin sulfate and keratan sulfate were 
without effect (Fig.  2).  While  laminin  was  quantitatively 
precipitated by heparin-agarose (not shown), only a  small 
fraction of dystroglycan from alkaline surface membrane ex- 
tracts specifically bound to heparin-agarose (Fig.  2). 
The ionic strength dependence (Fig. 1) and heparin inhibi- 
tion (Fig. 2) of laminin binding to dystroglycan suggest that 
polyanionic moieties are important to the laminin-binding 
activity of dystroglycan and further imply that the extensive 
posttranslational modification of dystroglycan may include 
glycosaminoglycan addition. However, treatment of dystro- 
phin-glycoprotein complex or alkaline  surface membrane 
extracts  with  nitrous  acid,  heparitinase,  chondroitinase 
ABC, or keratanase, all of which specifically remove glycos- 
aminoglycan chains (Soroka and Farquhar,  1991),  have no 
effect on the electrophoretic migration of dystroglycan, its 
antibody reactivity or 12q-laminin  binding while monoclo- 
nal antibodies specific for keratan sulfate and chondroitin 
sulfate failed to stain dystroglycan on nitrocellulose transfers 
(not shown). Dystroglycan is stained with Stains-AU and A1- 
cian Blue (Fig. 3), two dyes which bind polyanionic mole- 
cules including sialylatod glycoproteins and proteoglycans 
(King and Morrison, 1976; Kinne and Fisher, 1987). Neur- 
aminidase treatment of dystrophin-glycoprotein  complex re- 
suited in the characteristic 10 kD decrease in the size of dys- 
troglycan  (Ervasti  and  Campbell,  1991)  which  remained 
strongly reactive with Stains-All and Alcian Blue (Fig.  3), 
suggesting that the negatively charged sialic acid residues are 
not responsible for the interaction of these dyes with dys- 
troglycan. Neuraminidase treatment was also without effect 
on  12q-laminin  binding  to  dystroglycan (Fig.  3)  as  were 
N-Glycosidase F and O-Glycosidase treatment (not shown). 
Finally,  1,000-fold excesses of Jacalin,  peanut agglutinin, 
Maaclda amurensis lectin II, Con A or wheat germ aggluti- 
nin, lectins  specific for sugar  moieties common to  most 
O- or N-linked oligosaccharide side chains, had no effect on 
I'I-laminin binding to dystroglycan as assessed by the blot 
overlay method (not shown).  Taken together, these results 
suggest that polyanionic moieties that are not a component 
of the N- and O-linked oligosaccharides of dystroglycan are 
important in binding laminin. 
Chemical deglycosylation  with TFMS has been used to re- 
move N- or O-linked oligosaccharides as  well as  glycos- 
aminoglycan chains  from proteoglycans (Soroka and Far- 
qnhar,  1991).  When  alkaline  surface  membrane  extracts 
were chemically deglycosylated with  TFMS before SDS- 
PAGE, the affinity-purified antibodies to the fusion protein 
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Shown in A are corresponding autoradiograms of transfers  from 
SDS polyacrylamide gels containing 50 #g of  rabbit skeletal muscle 
surface membranes  (SM) and  10 #g of dystrophin-glycoprotein 
complex (DGC) which were overlaid  with nSI-laminin in the ab- 
sence  (12~I-LAM) or presence  of 1,000-fold  excesses  (wt/wt)  of 
heparin (HEP), chondroitin sulfate (ChS), or keratan sulfate (KS). 
Shown in B is a nitrocellulose transfer stained with monoclonal an- 
tibody IIH6 to dystroglycan containing equal volumes of alkaline 
surface membrane extracts (SM), the voids after incubation of  alka- 
line  surface  membrane  extracts  with  laminin-Sepharose  (LAb/ 
VOID), heparin-agarose (HEP VOID) or agarose (AGAR VOID), 
and the washed laminin-Sepharose  (/.AM SEPH), heparin-agarose 
(HEPAGAR), or agarose (AGAROSE). The molecular weight stan- 
dards (×10  -3  ) are indicated  on the left. 
Figure 3. Effect of neuraminidase  and alkalase treatment on laminin 
binding  to  dystroglycan.  Shown  are  SDS  polyacrylamide  gels 
stained  with Coomassie blue (CB), Stains-All  (Stains-All), or Al- 
cian Blue (Alcian Blue) which contain untreated control (Con), 
neuraminidase-tteated  (Neur) and  alkalase-treated  (Alk) dystro- 
phin-glycoprotein complex. Also shown are identical nitrocellulose 
transfers  stained  with monoclonal antibody IIH6 to dystroglycan 
(IIH6), polyclonal antibodies  specific  to fusion protein D repre- 
senting the cote protein sequence of  dystroglycan (Anti-FPD)  or the 
corresponding  autoradiogram  of  a  transfer  overlaid  with  125I- 
laminin (1251-LAM). The molecular weight standards  (xl0  -3) are 
indicated  on the left. 
representing the core protein of  dystroglycan stained a 57-kD 
band (Fig. 4 A) which corresponds well with the size of the 
core protein predicted  from cDNA sequence (Ibraghimov- 
Beskrovnaya et al.,  1992). Neither did the monoclonal anti- 
body IIH6 stain  the 57-kD band recognized by the fusion 
protein antibodies nor did the 57-kD band bind 125I-laminin 
(Fig. 4 A). Periodic acid treatment (Wu et al.,  1991) of alka- 
line surface membrane extracts also resulted in loss of  mono- 
clonal  antibody  IIH6 staining  and  ~25I-laminin  binding  to 
dystroglycan (not shown). Fusion proteins corresponding to 
sequences in the 43/156-kD dystrophin-associated glycopro- 
tein  precursor  protein  (lbraghimov-Beskrovnaya  et  al., 
1992) failed to bind 125I-laminin as assayed by the nitrocel- 
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cosylated dystroglycan or its 
corresponding fusion proteins 
do not bind laminin. Shown  in 
A are nitrocellulose transfers 
containing untreated control 
(Con)  and  TFMS-treated 
(TFMS)  alkaline  surface 
membrane  extracts stained 
with  monoclonal antibody 
11H6 to dystroglycan (IIH6) 
or affinity-purified  polyclonal 
antibodies specific to fusion 
protein  D  corresponding to 
the core protein sequence of 
dystroglycan (Anti-FPD) or 
the corresponding autoradio- 
gram  of a  transfer  overlaid 
with lzsI-laminin (125I-LAM). 
Shown in B is the correspond- 
ing autoradiogram of a trans- 
fer containing fusion proteins 
A  (FPA), B  (FIB),  and D 
(FPD)  representing  se- 
quences present  in the  core 
protein of dystroglycan over- 
laid  with  nSI-laminin (IzsI- 
/_AM).  The  ~s  on  the 
right mark the  migration of 
the  fusion  proteins which 
were detected with Ponceau S 
before the 125I-laminin  overlay 
procedure.  The  molecular 
weight standards (×10  -3  ) are 
indicated on the left. 
lulose overlay method (Fig. 4 B). These results suggest that 
negatively charged oligosaccharides other than sialic acid 
are necessary for the laminin-binding activity of dystrogly- 
can. On the other hand, digestion of the dystrophin-glyco- 
protein complex with the nonspecific protease alkalase (Lin- 
hardt et al.,  1992)  yielded a  100-kD  smear detected with 
Stains-All which did not bind 12q-laminin, monoclonal an- 
tibody IIH6, or fusion protein D-specific antibodies (Fig. 3). 
This result suggests that the core protein of dystroglycan is 
also necessary for laminin binding to dystroglycan. 
Laminin-Sepharose Binding of  Dystroglycan and the 
Dystrophin-Giycoprotein Complex 
Various Sepharose-conjugated extracellular matrix proteins 
were also tested for their ability to bind dystroglycan from 
alkaline surface membrane extracts of skeletal muscle. SDS 
polyacrylamide gel analysis demonstrated that dystroglycan 
was completely removed from the voids of alkaline surface 
membrane extracts incubated with laminin-Sepharose and 
remained  bound  to  the  laminin-Sepharose  after  several 
washes (Fig. 5 A). Dystrophin and the 59-kD dystrophin- 
associated protein, which are also present in alkaline surface 
membrane extracts (Ervasti and Campbell, 1991), remained 
in the laminin-Sepharose voids (not shown), indicating that 
neither protein bound to laminin-Sepharose. Dystroglycan 
was not bound by fibronectin-, gelatin-, collagen I-, or colla- 
gen IV-Sepharose (Fig. 5 B), further demonstrating that the 
interaction between laminin and dystroglycan is  selective 
and specific. 
One of the RGD recognition sequences present in laminin 
has been reported to be cryptic in the intact molecule (Au- 
mailley et al.,  1990).  Likewise, the SDS-denaturation and 
alkaline treatment necessary to isolate dystroglycan for use 
in the above assays may also have exposed laminin binding- 
sites on dystroglycan  which are not accessible when it is part 
of  the  dystrophin-glycoprotein complex.  Thus,  laminin- 
Sepharose binding of purified dystrophin-glycoprotein  com- 
plex was attempted. <25 % of the dystrophin-glycoprotein 
complex was bound by laminin-Sepharose in the presence of 
0.1% digitonin and 140 mM NaCI (not shown). An inhibi- 
tory effect  of detergents used to solubilize membrane-bound 
laminin receptors which bind '2~I-laminin with high affinity 
in a blot overlay assay but fail to bind laminin-Sepharose has 
been noted (Lesot et al.,  1983;  Smalheiser and Schwartz, 
1987; Douville et al., 1988). That the inhibitory effect of de- 
tergents on laminin binding is reportedly ionic strength de- 
pendent  (Lesot et  al.,  1983)  led us  to  attempt laminin- 
Sepharose binding of the dystrophin-glycoprotein complex 
in the presence of lower NaC1 concentrations. Gel analysis 
of the laminin-Sepharose voids after incubation with dystro- 
phin-glycoprotein complex in the presence of  0.1% digitonin 
and 44  mM NaC1 demonstrated specific and quantitative 
removal of the dystrophin-glycoprotein complex from the 
void while a  109-kD contaminant of dystrophin-glycopro- 
tein complex preparations was not bound by the laminin- 
Sepharose (Fig. 6). Recovery of the dystrophin-glycoprotein 
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surface  membrane extracts.  Shown  in A  is  a  Coomassie blue- 
stained  geF (CB) or identical  nitrocellulose  transfer  stained  with 
monoclonal antibody RI-I6 to dystroglycan (156-DAG) containing 
equal volumes of alkaline surface membrane extracts (pH 12 SM), 
laminin-Sepharose  void (/.am I6/d), three washes of the laminin- 
Sepharose  (gttsh 1, 2, and 3), or the washed laminin-Sepharose 
(Lain Seph). Shown in B  is  a  nitrocellulose  transfer  containing 
equal volumes of alkaline surface membrane extracts (SM) and the 
voids (It') and Sepharose pellets (P) of alkaline surface membrane 
extracts after incubation with laminin-, fibronectin-, gelatin-, colla- 
gen I-, or collagen IV-Sepharose which was stained with monoclo- 
hal antibody HI-I6  to dystroglycan. The molecular weight standards 
(xl0  -3) are indicated on the left. 
Figure 6. Laminin-Sepharose binding of the dystrophin-glycopm- 
tein complex.  Shown are a Coomassie  blue-stained gel (CB) or 
identical nitrocellulose transfer stained with monoclonal antibody 
IIH6 to dystroglycan (IIH6) containing equal volumes of untreated 
or alkaline-dissociated  dystrophin-glycoprotein  complex  (DGC), 
the voids after incubation with laminin-Sepharose  (LAM VOID), 
and the two subsequent  EDTA washes of the laminin-Sepharose 
(EDTA 1 and 2). The asterisk marks the position of the ,~109-kD 
contaminant  typically  found in dystrophin-glycoprotein  complex 
preparations.  The molecular  weight standards  (xl0  -3) are indi- 
cated on the left. 
complex in EDTA-elutions of the laminin-Sepharose (Fig. 6) 
demonstrated that binding of the complex to laminin-Seph- 
arose is reversible and dependent on divalent cations. As ob- 
served for tmcomplexed dystroglycan (Fig. 5 B), the dystro- 
phin-glycoprotein complex was not bound by fibronectin-, 
gelatin-, collagen I-, or collagen IV-Sepharose (not shown). 
Thus, these data demonstrate that the laminin-binding site is 
not a cryptic site, but is accessible when dystroglycan is as- 
sociated with the dystrophin-glycoprotein complex. 
We have previously demonstrated that all of the compo- 
nents  in  the  dystrophin-glycoprotein  complex  no  longer 
cosediment  on  sucrose  density  gradients  (Ervasti  et  al., 
1991) or coimmunoprecipitate (Ervasti and Campbell, 1991) 
after alkaline dissociation.  To determine whether the inter- 
action between laminin and dystroglycan is solely responsi- 
ble for the binding of the dystrophin-glycoprotein complex 
by laminin-Sepharose,  the void and the proteins bound to 
laminin-Sepharose  after  incubation  with  alkaline-dissoci- 
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sues. Shown are Coomassie blue-stained gels and portions of iden- 
tical  nitrocellulose  transfers  stained  with  monoclonal  antibody 
IIH6 to dystroglycan (IIH6) or afffinity-purified  polyclonal antibod- 
ies specific to fusion protein D corresponding to the core protein 
sequence of dystroglycan (Anti-FPD)  containing equal volumes of 
digitonin-solubilized skeletal muscle,  brain,  cardiac muscle,  or 
lung membranes (SOL), the voids after incubation of the solubi- 
lized membranes with laminin-Sepharose (VOID), or the EDTA 
eluates  from  each  laminin-Sepharose  after  extensive  washing 
(EDTA). Because the laminin-Sepharose was EDTA-eluted  in a vol- 
ume that  was  only one-half that  of the  original  solubilate, the 
amount of EDTA  eluate loaded on the gels represents twice the pro- 
tein equivalents loaded for the solubilates and voids. The migration 
of the molecular weight standards (224, 109, 72, 46, and 29 x  103 
from top to bottom) are  indicated on the left of the  Coomassie 
blue-stained  gel. Only the portion of the nitrocellulose transfers 
that lies between the 224,000 and 109,000 molecular weight stan- 
dards is illustrated. 
ated dystrophin-glycoprotein  complex was analyzed by SDS- 
PAGE and immunoblotting (Fig. 6). The laminin-Sepharose 
quantitatively bound dystroglycan from the alkaline-treated 
dystrophin-glycoprotein complex while dystrophin, the 59, 
50,  43,  35,  and  25  kD  dystrophin-associated proteins re- 
mained largely in the void (Fig. 6). Because dystroglycan ap- 
pears to be the only link between dystrophin and laminin, the 
quantitative binding of the dystrophin-glycoprotein  complex 
by laminin-Sepharose further demonstrates that dystrogly- 
can is a  stoichiometric component of the complex. 
Nonmuscle Dystroglycan Binds Laminin 
While skeletal muscle dystroglycan  exhibits binding properties 
consistent with its hypothesized function as a laminin recep- 
tor, the broad tissue distribution of dystroglycan (Ibraghimov- 
Beskrovnaya et al., 1992) raises the question of whether this 
protein also functions as a laminin receptor in nonmuscle tis- 
sues.  To address this question, digitonin-solubilized rabbit 
skeletal muscle, brain, cardiac muscle, and lung membranes 
were incubated with laminin-Sepharose.  After removal of 
the voids and extensive washing, the laminin-Sepharose ma- 
trices were eluted with incubation buffer containing 10 mM 
EDTA. The volume of the EDTA elution was equal to one- 
half that of the original solubilate applied to the laminin- 
Sepharose. Equal volumes of the resulting voids and EDTA 
eluates  were then compared to  the  original  solubilate by 
SDS-PAGE and immunoblotting (Fig.  7).  The Coomassie 
blue-stained gel revealed that none of the major protein con- 
stituents of the original solubilates were depleted from the 
laminin-Sepharose voids while very few proteins were de- 
tected  in  the  laminin-Sepharose  eluates  (compare  SOL, 
VOID, and EDTA Fig. 7, Top). Identical immunoblots were 
stained with monoclonal antibody IIH6 to dystroglycan or 
affinity-purified polyclonal antibodies  to  a  fusion protein 
corresponding to the core protein of dystroglycan (Fig.  7, 
Bottom).  Immunoblot  analysis  demonstrated  that  an  im- 
munoreactive band corresponding to dystroglycan was sig- 
nificantly reduced in the laminin-Sepharose voids of solubi- 
lized skeletal muscle, cardiac muscle, and lung membranes 
which was recovered in the EDTA eluates. Monoclonal an- 
tibody  IIH6  reacts  very weakly  with  brain  dystroglycan 
(Ibraghimov-Beskrovnaya et al., 1992) and was not useful in 
evaluating laminin-Sepharose binding to the brain. In addi- 
tion, the immunoreactive bands detected with the fusion pro- 
tein antibodies were barely detectable in the original solubi- 
lates  from  brain  making  it  impossible  to  evaluate  their 
depletion in the void. However, the fusion protein antibody 
clearly detected a band of '~120 kD, which is characteristic 
of  brain  dystroglycan  (lbraghimov-Beskrovnaya  et  al., 
1992), in the laminin-Sepharose EDTA eluate of solubilized 
brain (Fig. 7). These results demonstrate that dystroglycan 
of muscle and nonmuscle tissues binds laminin. 
The  presence  of  dystroglycan  in  nonmuscle  tissues 
presents  the  possibility  of the  existence of a  dystrophin- 
glycoprotein complex in non-muscle tissues which is similar 
to that found in skeletal muscle (Ervasti et al., 1990; Ohlen- 
dieck  et  al.,  1991b,  Ervasti  and  Campbell,  1991).  The 
laminin-Sepharose EDTA eluates from solubilized skeletal 
muscle, brain,  cardiac muscle, and lung membranes were 
concentrated tenfold and analyzed by SDS-PAGE, immuno- 
blotting,  and  12q-laminin  overlay  (Fig.  8).  Although  the 
Coomassie blue-stained gel revealed numerous proteins in 
the concentrated EDTA eluates from each tissue, only dys- 
troglycan was  detectable by  12q-laminin  overlay (Fig.  8). 
Most  notably apparent  from the  Coomassie blue-stained 
gel, however, was a 400-kD protein present in the eluates 
from skeletal and cardiac membranes but absent from brain 
and lung eluates.  The 400-kD protein in the skeletal and 
cardiac eluates was stained very intensely with sheep antise- 
rum  raised  against  the  dystrophin-glycoprotein complex 
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ates from various tissues. Shown are the lam- 
inin-Sepharose EDTA eluates  described  in 
Fig.  7  concentrated  lO-fold, electrophoreti- 
cally separated on an SDS polyacrylamide gel 
and stained with Coomassie  blue (Coomassie), 
an identical nitrocellulose transfer stained with 
sheep antiserum against the dystrophin-glyco- 
protein  complex and  monoclonal  antibody 
IIH6  to dystroglycan (Anti-DGC+IIH6), or 
the corresponding autoradiogram of a transfer 
overlaid with J25I-lamiuln  (lz51-Lam). The mo- 
lecular weight standards (xlO  -3) are indicated 
on the left. 
(Fig.  8)  as  well as  by monoclonal antibody XIXC2  (not 
shown) which is specific for dystrophin (Ervasti et ai., 1990; 
Ohlendieck et ai., 1991b; Ohlendieck and Campbell, 1991a; 
Ervasti and Campbell, 1991). In addition to dystrophin and 
dystroglycan, immunoreactive bands corresponding to the 
59, 50, 43, and 35 kD dystrophin-associated proteins were 
detected in both the skeletal and cardiac laminin-Sepharose 
EDTA eluates (Fig. 8).  With respect to the brain and lung 
laminin-Sepharose EDTA eluates, however, immunoreactive 
bands corresponding only to dystroglycan and the 43-kD 
dystrophin-associated glycoprotein were  detected  with  a 
cocktail of monoclonal antibody IIH6 and sheep antiserum 
to  the  dystrophin glycoprotein  complex  (Fig.  8).  These 
results demonstrate that the dystrophin-glycoprotein com- 
plex is similar in skeletal and cardiac muscle. Furthermore, 
the data suggest that if a dystrophin-glycoprotein complex 
exists in nonmuscle tissues, it is of grossly different structure 
and/or composition than the complex expressed in muscle. 
The Binding Sites on Dystroglycan for Monoclonal 
Antibody 111-16 and Laminin Overlap 
It is apparent from the results presented in Figs. 3 and 4 that 
treatments that result in the loss of staining of dystroglycan 
by monoclonal antibody IIH6 are accompanied by the loss 
of ~25I-laminin binding by dystroglycan, suggesting that the 
binding  sites  for monoclonal antibody IIH6  and  laminin 
overlap.  On the other hand, brain dystroglycan  is not detect- 
able  with  monoclonai  antibody IIH6  but  is  retained  by 
laminin-Sepharose,  which  implies that while the binding 
sites for monoclonal antibody IIH6 and laminin overlap, they 
are not identical. To test whether the binding of monoclonal 
antibody IIH6 affects laminin binding to dystroglycan, nitro- 
cellulose transfers containing dystrophin-glycoprotein com- 
plex were preincubated with tissue culture media containing 
either  monoclonal  antibody  IIHt,  VIA4~, which  is  also 
against dystroglycan (Ervasti et al.,  1990),  or monoclonai 
antibody XIXC2 to dystrophin (Ervasti et al., 1990; Ohlen- 
dieck et  al.,  1991b) and  subsequently overlaid with  125I- 
laminin (Fig.  9  A).  Preincubation with monoclonal IIH6 
almost completely inhibited t25I-laminin binding to dystro- 
glycan.  125I-laminin  binding to dystroglycan was not affected 
by preincubation of the blots with monoclonal antibodies 
VIA4, and XIXC2 (Fig. 9 A). Inclusion of increasing con- 
centrations of purified IIH6 also inhibited 125I-laminin  bind- 
ing to dystroglycan with complete inhibition observed at a 
IIH6/laminin ratio (wt/wt) of 100 (Fig. 9 B). Conversely, in- 
clusion of increasing concentrations of laminin to a limiting 
concentration of  purified IIH6, blocked IIH6 staining ofdys- 
troglycan with complete inhibition observed at a  laminin/ 
IIH6 (wt/w0 ratio of 10 (Fig. 9  C). These results demon- 
strate that the binding sites for IIH6 and laminin on dys- 
troglycan overlap. 
The Dystrophin-Glycoprotein Complex Interacts with 
Actin but Not Calcium or Calmodulin 
Sequence comparisons have shown that the NH2-terminal 
domain of  dystrophin is homologous to the actin-binding do- 
main of ct-actinin,  ~-spectrin, and actin-binding protein 120 
(Koenig et al.,  1988; Karinch et al.,  1990;  Bresnick et al., 
1990) and recently, fusion proteins corresponding to the se- 
quence  of the  NH2-terminal  domain  of dystrophin  have 
been shown to cosediment with F-actin (Hemmings et al., 
1992;  Way et ai.,  1992).  To test whether the dystrophin- 
glycoprotein complex is capable of interacting with actin, a 
cosedimentation assay based on that used to demonstrate 
dystrophin fusion protein/actin cosedimentation (Hemmings 
et al., 1992) was performed. In the absence of actin or in the 
presence of actin concentrations below the apparent critical 
concentration for polymerization, the dystrophin-glycopro- 
tein complex was found completely in the supernatant after 
a  30-min centrifugation at  100,000  g  while incubation of 
dystrophin-glycoprotein complex with actin concentrations 
above the apparent critical concentration for polymerization 
resulted in sedimentation of up to 50%  of the dystrophin- 
glycoprotein complex with the actin pellet (Fig.  10). These 
results indicate that the native dystrophin-glycoprotein  com- 
plex is capable of binding F-actin. 
As reviewed by Dubreuil et al. (1991), calcium has been 
shown to inhibit the binding of nonmuscle ot-actinin  and 
some isoforms of spectrin with actin and some spectrins have 
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plex with actin. Shown are a Coomassie blue-stained gel (Coomas- 
sie) or a nitrocellulose transfer stained with sheep polyclonal an- 
tisera to  the  dystrophin-glycoprotein complex  and  monoclonai 
antibody  IIH6  to  dystroglycan (Anti-DGC +  IIH6) containing 
equal volumes of supernatants (S) and pellets (P) of dystrophin- 
glycoprotein complex incubated with the indicated concentrations 
of rabbit muscle actin ~g/ml) and  subsequently centrifuged at 
100,000 g for 30 min. The asterisk marks the position of the ~  109- 
kD contaminant typically  found in dystrophin-glycoprotein  complex 
preparations. The molecular weight standards (x  10  -3) are indi- 
cated on the left. 
Figure 9. The binding sites on dystroglycan for IIH6 and laminin 
overlap.  Shown  in  A  are the  corresponding autoradiograms of 
nitrocellulose  transfers containing 4/zg of eleetrophoretically  sepa- 
rated dystrophin-glycoprotein  complex which were untreated (Con- 
trol) or first incubated with tissue culture media containing mono- 
clonai antibodies IIH6 (IIH6), VIA41 (VIA41), or XIXC2 (X/XC2) 
and subsequently overlaid with 12SI-laminin. The molecular weight 
standards  (x  10  -3)  are  indicated on  the  left.  Shown  in  B  are 
nitrocellulose transfers  containing  100  tzg  surface  membranes 
which were overlaid with 125I-laminin in the absence or presence 
of added pure monoclonal antibody IIH6 to attain the indicated 
IIH6/~2SI-laminin  ratio  (wt/wt).  Shown  in  C  are  nitrocellulose 
transfers containing  100  /~g surface membranes which were  in- 
cubated with pure monoclonal antibody IIH6 in the absence or 
presence of added laminin to attain the indicated laminin/IIH6 ratio 
(wt/wt). After extensive washing, IIH6 staining of the transfers il- 
lustrated in C was detected with tzSI-labeled goat anti-mouse IgM. 
Only the portion of the nitrocellulose  transfer that lies between the 
224,000 and 109,000  molecular weight standards is illustrated in 
Band C. 
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glycoprotein  complex does 
not bind Ca  2+ or Calmodulin. 
Shown is a Coomassie blue- 
stained gel (Coomassie) con- 
talning rabbit  brain ~, 
triads,  surface membranes 
(SM),  and dystrophin-glyco- 
protein complex (DGC). Also 
shown  are identical nitrocellu- 
lose  transfers overlaid with 
45CaC12  (~SCaClz)  or  125I- 
Caimodulin in the presence of 
I  rnM CaCI2 (IzsI-CaM) or I 
mM  EGTA  (~Zsl-CaM  + 
EGTA). The transfers used for 
~25I-Calmodulin overlay also 
contained  0.3  /~g  rat  brain 
Calmodulin  kinase II (CaM/t). 
The  molecular  weight stan- 
dards  (xl0  -3)  are  indicated 
on the left. 
been shown to bind calcium and calmodulin directly. The se- 
quence similarity between dystrophin, spectrin, and a-actinin 
suggests the possibility that calcium may regulate dystro- 
phin-actin interactions in a similar manner. As an initial test 
of this hypothesis, 45Ca2+ overlays of nitrocellulose transfers 
containing rabbit brain membranes, triads, and dystrophin- 
glycoprotein  complex  were  performed  under  conditions 
which have been used to demonstrate calcium binding to 
erythrocyte and brain spectrins (Wallis et al.,  1992).  45CaZ+ 
bound to the upper band of a doublet of ~ 260 kD in rabbit 
brain  membranes  which  is  presumably brain  o~-spectrin 
(Fig.  11,  Brain).  45Ca  2÷  bound  to  three  known  calcium- 
binding proteins of skeletal muscle; the ryanodine receptor, 
the sarcoplasmic reticulum Ca2+-ATPase and calsequestrin 
present in triads and as contaminants of crude surface mem- 
brane preparations (Fig.  11, Triads, SM).  However,  4~Ca  2+ 
did not bind to any component of the dystrophin-glycopro- 
tein complex (Fig.  11,  DGC).  Neither did ~25I-calmodulin 
overlay reveal any component of  the dystrophin-glycoprotein 
complex, in the presence of 1 mM CaC12 or 1 mM EGTA 
(Fig. 11), nor was dystrophin-glycoprotein  complex affinity- 
precipitated by calmodulin-Sepharose (not shown).  These 
data indicate that skeletal muscle dystrophin does not bind 
calcium or calmodulin which suggests that the dystrophin- 
actin interaction in skeletal muscle may not be regulated by 
calcium. The 45CaC12 overlay data further suggest that the 
calcium effect on laminin binding to dystroglycan (Fig. 1) is 
exerted through laminin and not dystroglycan. 
Discussion 
The results of the present study demonstrate that the native 
skeletal muscle dystrophin-glycoprotein complex is capable 
of binding both actin and larninin which supports a role for 
the complex in linking the actin-based cytoskeleton with the 
extracellular matrix. The drastic reduction of  the dystrophin- 
associated  glycoproteins  in  muscle  from  mdx  mice  and 
DMD patients (Ervasti et al., 1990; Ohlendieck and Camp- 
bell, 1991b; Ohlendieck et al., 1993) is evidence that altera- 
tion  in  dystrophin expression  profoundly affects  integral 
components of the sarcolemmal membrane. Absence of dys- 
trophin thus may compromise the integrity and flexibility of 
the sarcolemma, leading to either mechanical damage OOVeUer 
et al.,  1990;  Menke and Jockusch,  1991; Stedman et al., 
1991) or alteration in specific calcium-regulatory mecha- 
nisms (Franco and Lansman, 1990;  Turner et al.,  1991) of 
the sarcolemmal membrane. That dystrophin comprises two 
percent of sareolemmal protein (Ohlendieck et al.,  1991b) 
and five percent of the sarcolemmal cytoskeleton (Ohien- 
dieck and Campbell, 1991a) also supports a role for dystro- 
phin in maintaining skeletal muscle architecture.  Finally, 
dystrophin-associated glycoproteins are specifically reduced 
(Matsumura  et  al.,  1993)  or  absent  (Matsumura  et  al., 
1992b) from the muscle of patients with severe,  Ducbenne- 
like muscular dystrophies in which the abundance and struc- 
ture  of dystrophin is  normal.  These  results  suggest that 
the  cytoskeletal-sarcolemma-extraceUular matrix  linkage 
formed by the dystrophin-glycoprotein complex can be dis- 
rupted in a manner independent of a defect in dystrophin. 
Implication of  the four spectrin-like repeats of ot-actinin in 
binding the/~-integrin subunit led to the suggestion that the 
spectrin-like repeat domain of dystrophin may also interact 
with the sarcolemma through an integrin (Otey et al., 1990). 
However, there is currently no evidence for a direct interac- 
tion between dystrophin and integrin. While the fibronectin- 
specific  a5/31 integrin  has  been  observed  to  codistribute 
with dystrophin at  specific  stages  during development of 
chick embryonic myotubes (Lakonishok et al., 1992),  Dick- 
son et al. 0992) have observed distinct and nonoverlapping 
distribution patterns for dystrophin and the ~i  integrin in 
mouse myotubes. The results of the present work indicate 
that dystroglycan and the purified dystrophin-glycoprotein 
complex  interact with laminin but  do  not bind entactin, 
heparan  sulfate  proteoglycan,  fibronectin,  or  collagens. 
While many other extracellular matrix constituents remain 
to be tested for interaction with the dystrophin-glycoprotein 
complex, these data argue in favor of a specific interaction 
between laminin and the dystrophin-glycoprotein complex. 
The majority of experiments in this study used laminin 
purified from mouse EHS  tumors which is  composed of 
three subunits: a 400-kD A chain and two distinct 200-kD 
Ervasti and Campbell  Dystrophin-Glycoprotein Complex Binds Laminin  819 chains  designated  B1 and B2 (Timpl  et al.,  1987).  Recent 
studies have shown that laminin  is a member of a family of 
proteins which vary in their subunit structure and composi- 
tion.  Skeletal  muscle  predominately  expresses  a  protein 
named merosin,  which differs from laminin  in that  the A 
chain  is  replaced by a  structurally  homologous M  chain 
(Sanes  et al.,  1990;  Engvall  et al.,  1990).  Laminin,  and 
merosin to a  lesser extent,  can be further  substituted  by 
replacement  of the B1  chain  with a  homologous subunit 
named S-laminin  (Sanes et al., 1990; Engvall et ai., 1990). 
More recently, it was shown that cardiac muscle laminin con- 
tains  a  300-kD heavy chain  which is immunochemicaUy 
similar to the M chain of merosin (Paulsson et al.,  1991). 
We previously noted that both S-laminin (Sanes et al., 1990) 
and dystrophin-rdated protein are specifically  localized to 
the neuromuscular junction (Ohiendieck et al.,  1991a) and 
it is apparent  that merosin (Sanes et al.,  1990) and dystro- 
phin (Ohlendieck  et al., 1991a) exhibit similar distributions 
throughout the sarcolemmal membrane,  including the neuro- 
muscular junction. Recently, we demonstrated (Matsumura 
et al.,  1992a)  that dystrophin-related  protein is associated 
with a complex of glycoproteins that is identical or antigeni- 
cally similar to the complex associated with dystrophin  (Er- 
vasti  and  Campbell,  1991). In the present work, we have 
noted that merosin purified from human placenta also bound 
dystroglycan  as detected by the blot overlay method. Curi- 
ously,  the autoradiographic intensity  of ~25I-merosin bind- 
ing to dystroglycan did not appear as strong as that observed 
for 125I-laminin when performed in parallel.  While this  is 
not the anticipated result, there are several possible explana- 
tions  for our  observation.  SDS-polyacrylamide gel  dec- 
trophoretic analysis has demonstrated that purified merosin 
preparations contain polypeptides of 600, 300, and 180-200 
kD as well as minor components of 60-90 kD (Ehrig et al., 
1990; Ervasti,  J. M., and K. D. Campbell, unpublished ob- 
servations).  Thus, it is possible that the commercial merosin 
preparation  is impure or proteolyzed, either of which could 
account for its reduced signal  intensity  (in comparison to 
laminin)  in  the blot overlay  assay.  Furthermore,  there  is 
precedent for an integrin binding to a nonnative laminin with 
greater affinity than it exhibits for its native ligand (Sonnen- 
berg et al., 1991). Additional experiments  will be necessary 
to understand the nature of this apparent difference between 
laminin  and merosin in binding  dystroglycan. 
The emerging  importance of laminin  in skeletal  muscle 
development (Goodman et al.,  1989; yon der Mark et al., 
1991) raises the question of whether dystroglycan plays a role 
in skeletal  muscle differentiation.  In cultured muscle cells, 
dystrophin expression is not evident in myoblasts before fu- 
sion (Lev et al., 1987). Thus, laminin binding by dystrogly- 
can would not be expected to mediate any early events in 
skeletal  muscle differentiation,  assuming  that expression of 
the components of the dystrophin-glycoprotein  complex is 
coordinately regulated.  However, our finding that monoclo- 
hal antibody lItt6 blocks laminin  binding  to dystroglycan 
(Fig. 9) suggests that this antibody may be useful in further 
delineating the function of the dystrophin-glycoprotein  com- 
plex through  the possible perturbation  of laminin-dystro- 
glyean interactions  in vivo. 
Until recently, the actin-binding  properties of dystrophin 
have largely been speculated from its sequence homologies 
with well characterized  actin-binding proteins CKoenig  et al., 
1988;  Karinch  et al.,  1990;  Bresnick et al.,  1990).  Hem- 
mings et al.  (1992) demonstrated that a chimera comprised 
of the first 233 amino acids of dystrophin  and the last 645 
amino  acids of smooth muscle alpha-actinin  localized to 
actin-containing  structures when expressed in COS cells. In 
addition,  bacterially expressed fusion proteins correspond- 
ing to the putative actin-binding  domain of dystrophin  have 
been shown to cosediment with F-actin  (Hemmings  et al., 
1992; Way et al., 1992). However, the apparent dissociation 
constant of actin binding for one of these fusion proteins was 
estimated at 44 #M (Way et al.,  1992) which the authors 
noted was ten times greater than the K~ value obtained for 
filamin and two orders of magnitude  greater than the appar- 
ent K~ ~f ot-actinin dimer binding  to actin.  Although  the 
concentration dependence of dystrophin-glycoprotein  com- 
plex binding  to F-actin  was not rigorously determined, we 
observed significant  (50%)  dystrophin-glycoprotein  com- 
plex cosedimentation with F-actin using an effective dystro- 
phin concentration  of 0.1/zM (Fig.  10), suggesting that the 
native dystrophin-glycoprotein  complex binds F-actin  with 
an affinity similar to native a-actinin. Whether the difference 
between  dystrophin  fusion  proteins  and  the  dystrophin- 
glycoprotein complex with respect to F-actin binding affinity 
is due to an intact dystrophin molecule, dystrophin dimeriza- 
tion  or  a  modulatory  effect  by  one  of  the  dystrophin- 
associated glycoproteins will require further investigation. 
Furthermore, dystrophin  does not appear to be directly as- 
sociated with the myofibrillar actin filaments (Watkins et al., 
1988; Bonilla  et al.,  1988) which raises the issue of what 
actin-based structures skeletal muscle dystrophin may inter- 
act with in vivo. Peripheral  actin filaments emanating  from 
the Z lines and M lines of skeletal muscle myofibers have re- 
cently been identified (Bard and Franzini-Armstrong,  1991) 
while 3,-actin (Craig and Pardo,  1983) and dystrophin  (Por- 
ter  et al.,  1992)  are two of several  cytoskeletal proteins 
which exhibit discrete,  lattice-like  organizations  comprised 
of a longitudinal dement and transverse elements coincident 
with the I bands and M lines. The low abundance of 7-actin 
in adult skeletal muscle would also favor its interaction  with 
dystrophin from the standpoint of stoichiometry.  In addition, 
the  recent  identification  of  novel  actin-rdated  proteins 
(lees-Miller et al., 1992; Clark and Meyer, 1992) raises the 
possibility for discovery of a unique actin-like  protein in 
skeletal muscle which specifically binds dystrophin.  In the 
meantime,  our present results  demonstrate that the dystro- 
phin-glycoprotein  complex has the capacity to bind F-aetin. 
The cysteine-rich  region of dystrophin shows significant 
homology to a domain of Dictyostelium o~-actinin that con- 
talns  two Ca2+-binding sites (Koenig  et al.,  1988).  Thus, 
like nonmuscle ot-actinin and  some spectrins  (Dubreuil et 
al.,  1991), dystrophin-actin  interactions  are  conceivably 
affected by calcium.  However, calcium was not found to bind 
any component of the skeletal muscle dystrophin-glycoprotein 
complex (Fig.  11) under 4sCaCl2 overlay conditions identi- 
cal to those used in demonstrating  direct calcium binding to 
spectrin (Wallis et al.,  1992).  At variance  with Madhavan 
et al.  (1992), we have detected no interaction  between any 
component  of  the  dystrophin-glycoprotein  complex  and 
calmodulin  (Fig.  11). Since calmodulin is a eytosolic pro- 
tein,  the observation that biotinylated  calmodulin  interacts 
with 156 kD dystroglycan (Madhavan et al., 1992) conflicts 
strikingly with the proposition that it is wholly extracellular 
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1990; Ervasti and Campbell, 1991), laminin-binding proper- 
ties (Figs.  1-9),  membrane extraction properties  (Ohlen- 
dieck and Campbell, 1991a;  Ervasti and Campbell, 1991), 
and lack of  a predicted transmembrane domain (lbraghimov- 
Beskrovnaya et al.,  1992).  While the sum of these results 
provide support for calcium independent dystrophin-actin 
interactions in skeletal muscle, they leave open the possibil- 
ity that nonmuscle isoforms of dystrophin or its autosomal 
homologue dystrophin-related protein (Love et al.,  1989) 
may function in a calcium-dependent manner as is the case 
for nonmuscle o~-actinin. 
While the distribution of dystrophin in skeletal muscle 
(Porter et al., 1992) supports a role for dystrophin in stabiliz- 
ing the sarcolemmal membrane, its distribution in cardiac 
and smooth muscle (Byers et al.,  1991), cortical neurons 
(Lidov et al., 1990), and Torpedo  electrocytes (Yeadon et al., 
1991; Sealock et al., 1991) suggest that dystrophin may play 
more  varied  roles  in  noncontractile  tissues.  The  43-kD 
dystrophin-associated glycoprotein and  156-kD  dystrogly- 
can are also expressed in nonmuscle tissues (Ibraghimov- 
Beskrovnaya et al., 1992).  However,  while nonmuscle dys- 
troglycan binds laminin (Fig. 7), it does not appear to form 
a  complex  with  full-length dystrophin as  in  cardiac  and 
skeletal muscle (Fig. 8). Nonmuscle dystroglycan may bind 
to  the novel dystrophin isoforms which are  expressed  in 
some nonmuscle tissues (Rapaport et al., 1992; Blake et al., 
1992; Lederfein et al., 1992) at levels comparable to that of 
full-length dystrophin in striated muscle (Hoffman et al., 
1987). On the other hand, actin binding as a universal func- 
tion of dystrophin must also be reconsidered in light of these 
novel dystrophins, which completely lack the putative actin- 
binding domain (Rapaport et al., 1992;  Blake et al.,  1992; 
Lederfein et al.,  1992). 
In conclusion, our results demonstrate that the skeletal 
muscle dystrophin-glycoprotein  complex can bind both actin 
and laminin and suggest that dystrophin serves as a special- 
ized link between the actin cytoskeleton and the extracellular 
matrix. It is clear, however, that the same function cannot be 
immediately extrapolated to all tissues. Clarification of the 
role of dystrophin in nonmuscle tissues awaits further inves- 
tigation. 
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